Cart
0

Organ-on-Chip Market by Type (Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, and Lung-on-chip) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
SE_172555
Pages: 129
Nov 2017 | 6200 Views
 
Author's : Seapee Bajaj
Tables: 46
Charts: 35
 

Organ-On-Chip Market Overview:

Organ-on-chip Market was valued at $5 million in 2016, and is expected to reach $170 million by 2023, registering a CAGR of 63.2% from 2017 to 2023. An organ-on-a-chip (OOC) is a microfluidic cell culture device, which is developed using microchip manufacturing methods that contain continuously perfused chambers inhabited by living cells arranged to simulate tissue- and organ-level physiology. This chip develops a narrow channel for the blood and air flow in organs such as lung, gut, liver, heart, and others. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional 2D and 3D culture systems. Organ-on-chip offers a wide range of applications such as diseases modelling, patient stratification, and phenotypic screening.

The scope of organ-on-chip market includes potential opportunities for market players to enter the organ-on-chip market. The report provides in-depth market analysis of organ-on-chip market and outlines current trends, key driving factors, and potential areas for product investments.

The deployment modes of organ-on-chip devices applied in the industry are discussed in this report. The organ-on-chip market is consolidated by the presence of major key players such as Emulate, Organovo, and others. The report highlights the competitive landscape of these players to increase their market shares and sustain the intense competition in the industry.

Segment Overview

The global organ-on-chip market is segmented on the basis of type and geography. Based on type, the market is divided into heart-on-chip, human-on-chip, intestine-on-chip, kidney-on-chip, liver-on-chip, and lungs-on-chip. Geographically, the organ-on-chip market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get more information on this report : Request Sample Pages

Get more information on this report : Request Sample Pages

The heart-on-chip type has higher potential for growth in the global market. Lung-on-chip dominated the global organ-on-chip market in 2016, and is expected to continue its dominance during the forecast period.

In 2016, North America held the largest market share, due to innovation in advanced technologies and increase in healthcare applications. Asia-Pacific is anticipated to witness the highest growth rate during forecast period, due to lucrative opportunities offered by countries such as China, India, and Japan.

Top Impacting Factors

Surge in applications of OOC devices in the healthcare sector, increase in demand for organ-on-chip in drug screening, rise in in demand for OOCs for lung- & kidney-based organ culture, high cost of OOC devices, nascent stage of R&D pertaining to OOCs, and increase in research activities on OOC devices are the significant factors that impact the growth of the global organ-on-chip market. These factors are anticipated to either drive or hamper the market.

Get more information on this report : Request Sample Pages

Surge in Applications of Organ-on-chip Devices in the Healthcare Sector

Surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the growth of the global market. Organ-on-chip devices are applicable in real-time imaging, in-vitro analysis of biochemical, and genetic & metabolic activities of living cells in a functional tissue, which significantly fuel their adoption.

Increase in Demand for Organ-on-chip in Drug Screening

Drug screening is a cost-effective method used for rapidly reviewing samples. Scientists and researchers use organ-on-chip culture devices to monitor the effects of drugs in the body. Furthermore, drug toxicity or drug effectiveness in various organs of the body is checked using this technique, which boosts the market growth.

Rise in Demand for Lung- & Kidney-based Organ Culture Devices

Shortage of donor lungs for transplantation has led to significant number of patient deaths. Thus, rise in demand to develop laboratory-engineered, functional organs is anticipated to supplement the growth of the market. Recellularized solid organs can perform organ-specific functions for short span of time, which indicates the potential for clinical use of engineered solid organs in the future.

Key Benefits

  • This study comprises analytical depiction of the global organ-on-chip market with current trends and future estimations to depict the imminent investment pockets.
  • The overall market potential is determined to understand the profitable trends to gain a stronger foothold.
  • The report presents information related to key drivers, restraints, and opportunities with a detailed impact analysis.
  • The current market is quantitatively analyzed from 2016 to 2023 to highlight the financial competency of the market.
  • Porter’s Five Forces analysis illustrates the potency of the buyers and suppliers in the industry.

Organ-On-Chip Market Key Segments:

By Type

  • Heart-on-chip
  • Human-on-chip
  • Intestine-on-chip
  • Kidney-on-chip
  • Liver-on-chip
  • Lung-on-chip

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Key Market Players Profiled

  • Emulate, Inc.
  • AxoSim Technologies LLC
  • CN Bio Innovations
  • Hurel Corporation
  • Ascendance Biotechnology, Inc.
  • Insphero AG
  • Mimetas B.V.
  • Nortis Inc.
  • Organovo Holdings, Inc.
  • Tara Biosystems
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. RESEARCH METHODOLOGY

1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
1.3.4. Market segmentation

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top impacting factors

3.2.3.1. Surge in application of organ-on-chip devices in the healthcare sector
3.2.3.2. Increase in demand for organ-on-chip in drug screening
3.2.3.3. Rise in demand for lung- & kidney -based organ culture devices
3.2.3.4. High cost of organ-on-chip devices
3.2.3.5. Nascent stage in R&D pertaining to OOCs
3.2.3.6. Increase in research activities on organ-on-chip devices

3.3. PORTER’S FIVE FORCES

3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry

3.4. MARKET PLAYER POSITIONING, 2016
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Surge in application of organ-on-chip devices in the healthcare sector
3.5.1.2. Increase in demand for organ-on-chips in drug screening
3.5.1.3. Rise in demand for lung- & kidney-based organ culture devices

3.5.2. Restraints

3.5.2.1. High costs of organ-on-chip devices
3.5.2.2. Nascent stage in R&D pertaining to OOCs

3.5.3. Opportunity

3.5.3.1. Increase in research activities on organ-on-chip devices

Chapter: 4 ORGAN-ON-CHIP MARKET, BY TYPE

4.1. OVERVIEW
4.2. HEART-ON-CHIP

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. HUMAN-ON-CHIP

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. INTESTINE-ON-CHIP

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. KIDNEY-ON-CHIP

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. LIVER-ON-CHIP

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. LUNG-ON-CHIP

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 ORGAN-ON-CHIP MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast, by type
5.2.4. Market size and forecast, by country
5.2.5. U.S.

5.2.5.1. Market size and forecast

5.2.6. Canada

5.2.6.1. Market size and forecast

5.2.7. Mexico

5.2.7.1. Market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast, by type
5.3.4. Market size and forecast, by country
5.3.5. UK

5.3.5.1. Market size and forecast

5.3.6. Germany

5.3.6.1. Market size and forecast

5.3.7. France

5.3.7.1. Market size and forecast

5.3.8. Rest of Europe

5.3.8.1. Market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast, by type
5.4.4. Market size and forecast, by country
5.4.5. China

5.4.5.1. Market size and forecast

5.4.6. Japan

5.4.6.1. Market size and forecast

5.4.7. India

5.4.7.1. Market size and forecast

5.4.8. Australia

5.4.8.1. Market size and forecast

5.4.9. Rest of Asia-Pacific

5.4.9.1. Market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast, by type
5.5.4. Market size and forecast, by region
5.5.5. Latin America

5.5.5.1. Market size and forecast

5.5.6. Middle East

5.5.6.1. Market size and forecast

5.5.7. Africa

5.5.7.1. Market size and forecast

Chapter: 6 COMPANY PROFILES

6.1. AXOSIM TECHNOLOGIES LLC

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio

6.2. CN INNOVATIONS HOLDINGS LIMITED (CN BIO INNOVATIONS)

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Key strategic moves and developments

6.3. EMULATE, INC.

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.3.5. Key strategic moves and developments

6.4. ASCENDANCE BIOTECHNOLOGY, INC.

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Key strategic moves and developments

6.5. HUREL CORPORATION

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Key strategic moves and developments

6.6. INSPHERO AG

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.6.5. Key strategic moves and developments

6.7. MIMETAS B.V.

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Key strategic moves and developments

6.8. NORTIS INC.

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Key strategic moves and developments

6.9. ORGANOVO HOLDINGS, INC.

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance
6.9.6. Key strategic moves and developments

6.10. TARA BIOSYSTEMS, INC.

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL ORGAN-ON-CHIP MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. HEART-ON-CHIP MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 3. HUMAN-ON-CHIP MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. INTESTINE-ON-CHIP MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. KIDNEY-ON-CHIP MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. LIVER-ON-CHIP MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. LUNG-ON-CHIP MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. ORGAN-ON-CHIP MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. NORTH AMERICA ORGAN-ON-CHIP MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA ORGAN-ON-CHIP MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11. EUROPE ORGAN-ON-CHIP MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12. EUROPE ORGAN-ON-CHIP MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 13. ASIA-PACIFIC ORGAN-ON-CHIP MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 14. ASIA-PACIFIC ORGAN-ON-CHIP MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15. LAMEA ORGAN-ON-CHIP MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 16. LAMEA ORGAN-ON-CHIP MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. AXOSIM: COMPANY SNAPSHOT
TABLE 18. AXOSIM: OPERATING SEGMENTS
TABLE 19. AXOSIM: PRODUCT PORTFOLIO
TABLE 20. CNI: COMPANY SNAPSHOT
TABLE 21. CNI: OPERATING SEGMENTS
TABLE 22. CNI: PRODUCT PORTFOLIO
TABLE 23. EMULATE: COMPANY SNAPSHOT
TABLE 24. EMULATE: OPERATING SEGMENTS
TABLE 25. EMULATE: PRODUCT PORTFOLIO
TABLE 26. ASCENDANCE: COMPANY SNAPSHOT
TABLE 27. ASCENDANCE: OPERATING SEGMENTS
TABLE 28. ASCENDANCE: PRODUCT PORTFOLIO
TABLE 29. HUREL: COMPANY SNAPSHOT
TABLE 30. HUREL: OPERATING SEGMENTS
TABLE 31. HUREL: PRODUCT PORTFOLIO
TABLE 32. INSPHERO: COMPANY SNAPSHOT
TABLE 33. INSPHERO: OPERATING SEGMENTS
TABLE 34. INSPHERO: PRODUCT PORTFOLIO
TABLE 35. MIMETAS: COMPANY SNAPSHOT
TABLE 36. MIMETAS: OPERATING SEGMENTS
TABLE 37. MIMETAS: PRODUCT PORTFOLIO
TABLE 38. NORTIS: COMPANY SNAPSHOT
TABLE 39. NORTIS: OPERATING SEGMENTS
TABLE 40. NORTIS: PRODUCT PORTFOLIO
TABLE 41. ORGANOVO: COMPANY SNAPSHOT
TABLE 42. ORGANOVO: OPERATING SEGMENTS
TABLE 43. ORGANOVO: PRODUCT PORTFOLIO
TABLE 44. TARA BIOSYSTEMS: COMPANY SNAPSHOT
TABLE 45. TARA BIOSYSTEMS: OPERATING SEGMENTS
TABLE 46. TARA BIOSYSTEMS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 1. ORGAN-ON-CHIP MARKET SEGMENTATION
FIGURE 2. EXECUTIVE SUMMARY
FIGURE 3. TOP WINNING STRATEGIES, 2015-2017 (%)
FIGURE 4. TOP WINNING STRATEGIES, 2015-2017
FIGURE 5. TOP INVESTMENT POCKETS
FIGURE 6. TOP IMPACTING FACTORS (2016 - 2023)
FIGURE 7. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 8. LOW-TO-MODERATE BARGAINING POWER OF BUYERS
FIGURE 9. MODERATE-TO-HIGH THREAT OF SUBSTITUTES
FIGURE 10. MODERATE-TO-HIGH THREAT OF NEW ENTRANTS
FIGURE 11. MODERATE COMPETITIVE RIVALRY
FIGURE 12. KEY PLAYER POSITIONING OF ORGAN-ON-CHIP COMPANIES, 2016
FIGURE 13. DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 14. GLOBAL ORGAN-ON-CHIP MARKET, BY TYPE
FIGURE 15. ORGAN-ON-CHIP MARKET SHARE AND CAGR, BY GEOGRAPHY
FIGURE 16. NORTH AMERICA ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 17. U.S. ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 18. CANADA ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 19. MEXICO ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 20. EUROPE ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 21. UK ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 22. GERMANY ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 23. FRANCE ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 24. REST OF EUROPE ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 25. ASIA-PACIFIC ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 26. CHINA ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 27. JAPAN ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 28. INDIA ORGAN-ON-CHIP MARKET, 2016-2023 (MILLION)
FIGURE 29. AUSTRALIA ORGAN-ON-CHIP MARKET, 2016-2023 (MILLION)
FIGURE 30. REST OF ASIA-PACIFIC ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 31. LAMEA ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 32. LATIN AMERICA ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 33. MIDDLE EAST ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 34. AFRICA ORGAN-ON-CHIP MARKET, 2016-2023 ($MILLION)
FIGURE 35. ORGANOVO: NET SALES, 2014-2016 ($MILLION)

 

The global organ-on-chip market is expected to grow at a significant rate of 63.2% from 2017 to 2023. An organ-on-a-chip (OOC) is a microfluidic cell culture device, which is developed using microchip manufacturing methods that contain continuously perfused chambers inhabited by living cells arranged to simulate tissue- and organ-level physiology.

Surge in applications of organ-on-chip devices in healthcare sector is expected to boost the growth of the organ-on-chip market during the forecast period. In addition, increase in demand for organ-on-chip in drug screening is expected to fuel the market growth. However, nascent stage in R&D pertaining to OOCs is anticipated to hamper the demand of organ-on-chip market.

The global organ-on-chip market is expected to reach $170 million by 2023. Human-on-chip segment is expected to witness significant growth, due to rise in number of deaths by different cardiac diseases such as heart failure. Geographically, the North America market accounted for the highest share of revenue in 2016, followed by Europe. The Asia-Pacific organ-on-chip market is anticipated to grow at the highest growth rate during the forecast period.

The key market players in the global organ-on-chip industry have various adopted various strategies such as product launches, partnerships, business expansions, promotional activities, and strategic alliances to create awareness about the technology and increase its adoption across various verticals.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Organ-on-Chip Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Semiconductor and Electronics on Knowledge Tree Platform
Free Demo